This trial is testing a decision aid to help patients with non-small cell lung cancer make better decisions about their care. The goal is to improve patient involvement, satisfaction, and communication with their physician.
2 Primary · 8 Secondary · Reporting Duration: From enrollment to the end of follow-up at 8 weeks
Active Control
Experimental Treatment
100 Total Participants · 2 Treatment Groups
Primary Treatment: Questionnaire Administration · No Placebo Group · N/A
Age Any Age · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: